(Q36402695)

English

High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

0 references

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

1

object named as

Yen Phung

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

author name string

Wei Gao

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Yan-Gao Man

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Satoshi Nagata

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Mitchell Ho

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

23 July 2012

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Monoclonal Antibodies

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

592-599

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Monoclonal antibodies for the treatment of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

Therapeutic potential of targeting glypican-3 in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

Glypican-3: a new target for cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

Have we overestimated the benefit of human(ized) antibodies?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

Mesothelin as a potential therapeutic target in human cholangiocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

Production of monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

Mouse monoclonal antibodies in biological research: strategies for high-throughput production

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3499300

30 September 2017

Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling

1 reference

https://api.crossref.org/works/10.4161%2FMABS.20933

21 January 2018

Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.4161%2FMABS.20933

21 January 2018

Immunotoxin therapy of cancer

1 reference

https://api.crossref.org/works/10.4161%2FMABS.20933

21 January 2018

Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22820551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization

1 reference

https://pubmed.ncbi.nlm.nih.gov/22820551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22820551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glypican-3 as a serum marker for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22820551

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4161/MABS.20933

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36402695&oldid=1932933492"